Program On Regulation, Therapeutics, And Law (PORTAL)
Academic research center at Brigham and Women's Hospital & Harvard Medical School studying the clinical, economic, and legal aspects of medication use.
RETHINKING MEDICATIONS by Jerry Avorn - Out Now! https://rethinkmeds.info/
@usha.bsky.social
I cover health equity for STAT. Yes my job is harder these days. Signal ID: usha.22
@tombollyky.bsky.social
Bloomberg Chair in Global Health and Senior Fellow in Int'l Economics & Development @CFR_org. Founder of Think Global Health. Law Prof sometimes.
@bmj.com
The BMJ is patient centred, evidence based, and independent. Help us improve the health of our world with the best science, journalism, education, and comment.
@andrewedunn.bsky.social
Reporter @ Endpoints News Covering biotech, pharma, AI, and more — the future of medicine adunn@endpointsnews.com
@nicoledefeudis.bsky.social
Biopharma reporter at Endpoints News | nicole@endpointsnews.com
@endpts.com
We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com.
@jlme-journal.bsky.social
The Journal of Law, Medicine & Ethics (JLME) is a leading peer-reviewed journal for research at the intersection of law, health policy, ethics, and medicine.
@icer-review.bsky.social
Encouraging fair pricing, fair access, and future innovation within the US health care system | Reposts not endorsements
@sluhealthlaw.bsky.social
Official profile of the Saint Louis University School of Law Center for Health Law Studies. Educating law students for health law practice since 1982.
@tuftscevr.bsky.social
Center for the Evaluation of Value and Risk in Health at Medical Center. Posts and reposts are not endorsements. https://cevr.tuftsmedicalcenter.org/
@brianreid.bsky.social
I have a newsletter. It's called Cost Curve. I write a lot about dull things like 340B reform and benefit design and the Value Flower. You can probably Google it.
@bobjherman.bsky.social
Health care business reporter for @statnews.com and its Health Care Inc. newsletter. Contact: bob.herman@statnews.com or bobjherman.09 on Signal. Sign up: https://www.statnews.com/signup/health-care-inc/
@leah-rand.bsky.social
Researcher and lecturer Program on Regulation, Therapeutics, and Law @portalresearch.org and Harvard Medical School Interests: prescription drugs, bioethics, health technology assessment, and justice
@jamielove.bsky.social
I work at https://keionline.org/jamie. Best known for work on intellectual property rights, and find most interesting ways to reform incentives and also build out global norms and mechanisms to increase the supply of public goods. Economics background.
@wbfeldman.bsky.social
Lung & ICU doctor | Faculty @harvardmed & @PORTAL_Research | Ethics Co-Chair @BrighamWomens
@sampat.bsky.social
Professor & Economist at ASU and NBER, based at the Consortium for Science, Policy, and Outcomes (CSPO) in DC. Current research focuses on the history and political economy of U.S. S&T policy, the economics of the NIH, and pharmaceutical patent policy.
@aschwartz.bsky.social
MD-PhD professing at the University of Pennsylvania. Health, economics, and health economics.
@ojwouters.bsky.social
Associate Professor at Brown University Investigating global disparities in access to medicines
@alecgaffney.bsky.social
Vice President, Regulatory Policy & Intelligence at POLITICO's AgencyIQ. Writing about how the FDA regulates medical products for 15+ years. Author of the newsletter 'FDA Today'. Signal: AlecGaffney.01
@leorahorwitzmd.bsky.social
Director, Center for Healthcare Innovation and Delivery Science, NYU Langone Health; #NIHRECOVER adult PI; general internist; quality/safety/healthcare delivery; mom of 3 boys. Posts are my own. #MedSky
@imakglobal.bsky.social
We are a team of lawyers, scientists, and health experts challenging systemic injustice and advocating for health equity in drug development and access.
@yalecrrit.bsky.social
The Collaboration for Regulatory Rigor, Integrity, & Transparency (CRRIT), based out of Yale Medical, Public Health, & Law schools, researches the regulation, approval, & coverage of medical drugs & devices to advance policies that improve patient health.
@kffhealthnews.org
A national newsroom that produces in-depth journalism about health issues; a core program of @KFF.org. Also publishes California Healthline.
@edwincpark.bsky.social
Health policy especially Medicaid, CHIP and the Affordable Care Act. Research Professor at the Center for Children and Families (CCF) at Georgetown University’s McCourt School of Public Policy. ccf.georgetown.edu
@tahiramin.bsky.social
CEO @imakglobal.bsky.social. Renegade IP lawyer. Critically rethinking IP laws through (neo)colonial/neoliberal systems of power, and that empty word “innovation”.
@mbarber.bsky.social
Health economics, law, global health, and access to medicines. https://melissajbarber.github.io. Views my own.
@cmorten.bsky.social
Associate clinical professor at Columbia Law. Visiting at NYU Law Fall 2024. Director of CLS's Science, Health & Information Clinic (SHIC) (https://bit.ly/3dG53BO). He/him.
@akapczynski.bsky.social
Law prof at Yale, LPE Associate Justice, all things political economy, but not yr grandpas version.
@araymakers.bsky.social
Health economist & research fellow with the Program on Regulation, Therapeutics, & Law (PORTAL) at Harvard Medical School. Interests: drug pricing/policy, health technology assessment, climate change. Squamish, BC www.linkedin.com/in/araymakers
@walidgellad.bsky.social
Professor of Medicine at the University of Pittsburgh. Director, Center for Pharmaceutical Policy and Prescribing (@pittcp3.bsky.social)
@thewonkologist.bsky.social
Medical oncologist and health services researcher. Focusing on health care costs, physician-industry COI, and oncology reimbursement reform. Opinions mine.
@asarpatwari.bsky.social
Assistant Professor of Population Medicine Harvard Pilgrim Health Care Institute and Harvard Medical School Faculty Director, JD/MPH Program Harvard T.H. Chan School of Public Health
@hollylynchez.bsky.social
Academic lawyer/bioethicist studying pharmaceutical policy, access to investigational medicines, IRB quality (www.aereo.org), and clinical research ethics and regulation, with a splash of psychedelics.
@dusetzinas.bsky.social
Health services researcher at Vanderbilt Health Policy. Avid coffee drinker, investigator of drug policies & prices. RT not an endorsement. Opinions are mine.
@drjoshs.bsky.social
Posting on public health topics … some interesting photos if I manage to take them … & occasionally the Baltimore Orioles.
@eddiecliff.bsky.social
haematology registrar PMCC & RMH | research affiliate, PORTAL, BWH/HMS | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer
@sarahkarlin-smith.bsky.social
Journalist covering intersection of pharma, health policy & politics for the Pink Sheet. On Signal at SarahKarlinSmith.34 KFF Health News’ ‘What The Health?’ panelist. Co-created Prescription PULSE at Politico. GWU alum, dabbled in SMPA adjunct-ness.
@pittcp3.bsky.social
Center for Pharmaceutical Policy and Prescribing at the University of Pittsburgh. Our research helps improve quality, safety, & efficiency of medication use.
@rachelsachs.bsky.social
Law professor. Researching and writing about innovation and access to new healthcare technologies, mostly in health law, FDA law, and patent law.
@drsinhaesq.bsky.social
MD JD MPH • Asst Prof @SLUHealthLaw.bsky.social @SLULAW.bsky.social • Former #NUSLHealth @PORTALResearch.org #HarvardMIT_CRS #HeForShe • 🇮🇸🇮🇳🇺🇸
@kellyanderson.bsky.social
I research insurance design, Medicare Advantage, and high-cost prescription drugs. Faculty at the University of Colorado School of Pharmacy. Alum of Hopkins Health Policy and Management and UVA Batten. Find me in the mountains
@assumenormality.bsky.social
Assistant Professor of Health Policy at Vanderbilt w/ expertise in access to care, Medicaid, Veterans' health. Formerly Boston University, Department of Defense, US Army (CIV). Views are my own. #HealthEconomics #PublicHealth
@audreydzhang.bsky.social
Primary care physician and health services researcher. General medicine fellow at Harvard/BIDMC. Studying how to improve quality of care for older adults. https://linktr.ee/audreydzhang
@akesselheim.bsky.social
Professor of Medicine, Brigham and Women's Hospital/Harvard Medical School; Director, Program On Regulation, Therapeutics, And Law (PORTAL)
@zekeemanuel.bsky.social
World leader in health policy, widely cited bioethicist, UPenn provost and professor, and oncologist. Latest book: "Which Country Has the World's Best Health Care?"
@reshmagar.bsky.social
Assistant Professor, primary care physician, and health services researcher at Yale School of Medicine, Co-Director of the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT); *views expressed here are my own*